Ekso Bionics Holdings Inc (NASDAQ: EKSO, formerly trading as CHRN) is a medical device company that designs, develops, and commercializes exoskeleton products for human use. Revenue is generated through the sale and distribution of wearable robotic exoskeleton devices, with products including Nomad and BalanceTutor disclosed in the FY2025 10-K filed February 23, 2026. The company is listed on the Nasdaq Capital Market. The filing excerpts do not provide segment revenue figures, customer concentration data, geographic revenue breakdown, named competitors, or capital structure details sufficient to characterize the business further with precision. What is confirmed is that the company's commercial focus spans exoskeleton device design, manufacturing, supply chain management, and potential strategic partnerships as of the fiscal year ended December 31, 2025.

Revenue model

Device sales and commercialization of exoskeleton products, including Nomad and BalanceTutor, as disclosed in the FY2025 10-K. Specific pricing model, subscription components, or unit economics are not detailed in the available filing excerpts.

Products and services

Exoskeleton devices for human use, including Nomad and BalanceTutor, as named in the FY2025 10-K filed February 23, 2026.

Customers and end markets

The filing excerpts do not specify customer types, end market segments, or customer concentration data.

Value-chain role

Device manufacturer and commercializer of wearable robotic exoskeletons, with involvement in design, development, manufacturing, supply chain, and distribution.

Geographic exposure

The filing excerpts do not provide geographic revenue breakdown or specific market footprint data.

Source: SEC 10-K, filed 2026-02-23

Industry: General Industrial Machinery & Equipment, NEC Peers: Abbott Laboratories Vivos Inc ALR TECHNOLOGIES INC. REMSleep Holdings Inc BIOLASE, INC ENDRA Life Sciences Inc Heartbeam Inc NeuroMetrix, Inc. PetVivo Holdings Inc Vaso Corp